Skip to main content

Nerlynx Side Effects

Generic name: neratinib

Medically reviewed by Drugs.com. Last updated on Feb 25, 2024.

Note: This document contains side effect information about neratinib. Some dosage forms listed on this page may not apply to the brand name Nerlynx.

Applies to neratinib: oral tablet.

Serious side effects of Nerlynx

Along with its needed effects, neratinib (the active ingredient contained in Nerlynx) may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.

Check with your doctor immediately if any of the following side effects occur while taking neratinib:

More common

Less common

Rare

Other side effects of Nerlynx

Some side effects of neratinib may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects.

Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:

More common

Less common

For Healthcare Professionals

Applies to neratinib: oral tablet.

General

The most common adverse reactions (more than 5%) were diarrhea, nausea, abdominal pain, fatigue, vomiting, rash, stomatitis, decreased appetite, muscle spasms, dyspepsia, increased AST or ALT, nail disorder, dry skin, abdominal distention, decreased weight, and urinary tract infection.[Ref]

Gastrointestinal

Very common (10% or more): Diarrhea (95%), nausea (43%), abdominal pain (36%), vomiting (26%), stomatitis (14%), dyspepsia (10%)

Common (1% to 10%): Abdominal distention, dry mouth[Ref]

Other

Very common (10% or more): Fatigue (27%)[Ref]

Dermatologic

Very common (10% or more): Rash (18%)

Common (1% to 10%): Nail disorder, rash, skin fissures[Ref]

Metabolic

Very common (10% or more): Decreased appetite (12%)

Common (1% to 10%): Decreased weight, dehydration[Ref]

Musculoskeletal

Very common (10% or more): Muscle spasms (11%)[Ref]

Genitourinary

Common (1% to 10%): Urinary tract infection[Ref]

Hepatic

Common (1% to 10%): Increased ALT, increased AST[Ref]

Respiratory

Common (1% to 10%): Epistaxis[Ref]

Cardiovascular

Frequency not reported: Hypotension[Ref]

Renal

Frequency not reported: Renal failure[Ref]

Frequently asked questions

References

1. Product Information. Nerlynx (neratinib). Puma Biotechnology, Inc. 2017.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Some side effects may not be reported. You may report them to the FDA.